[EN] N-ACYLAMINOBENZENE DERVATIVES AS SELECTIVE MONOAMINE OXIDASE B INHIBITORS<br/>[FR] DERIVES DE N-ACYLAMINOBENZENE COMME INHIBITEURS DE LA MONOAMINE OXYDASE B SELECTIFS
申请人:HOFFMANN LA ROCHE
公开号:WO2003099763A1
公开(公告)日:2003-12-04
This invention relates to N-acylamino aryl derivatives of the general formula (I), wherein R1 is halogen, halogen-(C1-C6)-alkyl, cyano, C1-C6-alkoxy or halogen-(C1-C6)-alkoxy; R21, R22, R23 and R24 independently from each other are selected from the group consisting of hydrogen, (C1-C6)-alkyl, halogen, halogen-(C1-C6)-alkyl, hydroxy, C1-C6-alkoxy or -CHO; R3 is hydrogen or C1-C3-alkyl; R4, R5 independently from each other are selected from the group consisting of hydrogen, C1-C6-alkyl, C1-C6-alkoxy or -COO(C1-C6)alkyl; or R4 and R5 form together with the C-atom to which they are attach a C3-C7-cycloalkyl ring; R6 is -CO-NR7R8; -COO(C1-C6)-alkyl, -CN, -NR2 or -NHC(O)R; R7 and R8 independently from each other are selected from the group consisting of hydrogen, C1-C6-alkyl, NH2 or hydroxy; R is hydrogen or C1-C6-alkyl; n is 0, 1, 2 or 3. X is -CHRO, -OCHR, -CH2S-, -SCH2-, -CH2CH2-, -CH=CH- or -C≡C-; and to pharmaceutically active acid addition salts thereof. It has been found that the compounds of general formula (I) are selective monoamine oxidase B inhibitors and they are therefore useful in the treatment of diseases mediated by monoamine oxidase B inhibitors, for example for the treatment of Alzheimer’s disease or senile dementia.
这项发明涉及一般式(I)的N-酰氨基芳基衍生物,其中R1是卤素,卤代-(C1-C6)-烷基,氰基,C1-C6-烷氧基或卤代-(C1-C6)-烷氧基;R21、R22、R23和R24彼此独立地选自氢,(C1-C6)-烷基,卤素,卤代-(C1-C6)-烷基,羟基,C1-C6-烷氧基或-CHO的群;R3是氢或C1-C3-烷基;R4、R5彼此独立地选自氢,C1-C6-烷基,C1-C6-烷氧基或-COO(C1-C6)烷基的群;或R4和R5与它们连接的C原子一起形成一个C3-C7-环烷基环;R6是-CO-NR7R8;-COO(C1-C6)-烷基,-CN,-NR2或-NHC(O)R;R7和R8彼此独立地选自氢,C1-C6-烷基,NH2或羟基;R是氢或C1-C6-烷基;n为0、1、2或3。X是-CHRO,-OCHR,-CH2S-,-SCH2-,-CH2CH2-,-CH=CH-或-C≡C-;以及其药用活性酸盐。已发现一般式(I)的化合物是选择性单胺氧化酶B抑制剂,因此它们在治疗由单胺氧化酶B抑制剂介导的疾病中很有用,例如用于治疗阿尔茨海默病或老年性痴呆症。